Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00825799 · ClinicalTrials.gov registry record
Serum Markers as a Bioassay for Unipolar Depression
A clinical trial of Major Depression, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- Completed
- Registry status
- 160
- Enrollment target
- 1
- Study location
NCT00825799 is a study of Major Depression that has completed, run by Steward St. Elizabeth's Medical Center of Boston. The registered enrollment target is 160 participants, below the 322-participant average among 28 other Major Depression trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00825799, a study of Major Depression, has completed, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the study is to validate a biomarker assay for unipolar depression based on serum proteins involved in inflammation, metabolism, and stress response. The study will compare patients with a current major depressive episode to individuals with no history of depression. The hypothesis is that the assay can serve as a diagnostic tool that would be more objective than standard diagnostic questionnaires.
Conditions Studied
Study Locations (1)
Massachusetts
- Steward St. Elizabeth's Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2007-11 |
| Est. Completion | 2011-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00825799
The ClinicalTrials.gov registry entry for NCT00825799 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 322-participant average among 28 other Major Depression trials with a reported enrollment target (50% lower). The listed sponsor is Steward St. Elizabeth's Medical Center of Boston, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Major Depression appearing as the primary indexed condition, and to 0 interventions.
NCT00825799 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00825799 about?
NCT00825799 is a clinical study titled "Serum Markers as a Bioassay for Unipolar Depression". The goal of the study is to validate a biomarker assay for unipolar depression based on serum proteins involved in inflammation, metabolism, and stress response. The study will compare patients with a current major depressive episode to individuals with no history of depression. The hypothesis is th...
What is the current status of trial NCT00825799?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2007-11. Estimated completion is 2011-05.
What conditions does trial NCT00825799 study?
This clinical trial studies the following conditions: Major Depression.
Who is sponsoring clinical trial NCT00825799?
This trial is sponsored by Steward St. Elizabeth's Medical Center of Boston, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00825799 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
RECRUITING · Phase 1
-
University of Iowa Interventional Psychiatry Service Patient Registry
RECRUITING
-
NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder
RECRUITING
-
Leucine in Midlife Depression
RECRUITING · Phase 2
-
Ketamine Alcohol (in Treatment-Resistant Depression)
RECRUITING · Phase 2
-
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.